Trademark: 79250188
Word
MEDIGENE
Status Date
Tuesday, December 17, 2019
Registration Number
5934628
Registration Date
Tuesday, December 17, 2019
Filing Date
Tuesday, July 17, 2018
Published for Opposition
Tuesday, October 1, 2019
5 Pharmaceutical and veterinary preparations namely, cellular preparations, T-cell preparations and DC (dendritic cell) preparations for the treatment of cancer and use in immunotherapy; medical compositions for the treatment of hematological and solid tumors, tumor precursors; test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting primarily of antibodies, test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting primarily of soluble T-cell receptors, test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting primarily of genetically modified cells and test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting of a composition of antibodies, soluble T-cell receptors and genetically modified cells; diagnostic and therapeutic preparations for medical purposes being mixtures of therapeutically active cells in a suitable medium, in particular produced using molecular biological, biotechnological and genetic methods
44 Medical and veterinary medical services, in particular extracting of blood and/or tissue samples and analysis and evaluation relating thereto for medical purposes
42 Services in molecular biology, namely, research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological and genetic methods, and in the field of screening for compounds with pharmaceutical properties; development of test methods and test kits in the field of hematological and solid tumor immunology; biological cell analyses; development of individualized medicine, development of treatment plans and therapy adapted for individual patients; all the foregoing being for scientific and therapeutic purposes; development of adoptive T cell therapy; development of DC vaccines; development of cellular tumour therapy; development of tumour markers; development of diagnostic and therapeutic antibodies; cell analyses; development of individualised medicine, development of treatment plans and therapy adapted for individual patients
Color is not claimed as a feature of the mark.
Aug 4, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 4, 2022
Teas Change Of Correspondence Received
Aug 4, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 4, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 4, 2022
Teas Change Of Owner Address Received
May 1, 2020
Final Decision Transaction Processed By Ib
Mar 28, 2020
Final Disposition Notice Sent To Ib
Mar 28, 2020
Final Disposition Processed
Mar 17, 2020
Final Disposition Notice Created, To Be Sent To Ib
Dec 17, 2019
Registered-Principal Register
Oct 5, 2019
Notification Processed By Ib
Oct 1, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 1, 2019
Published For Opposition
Sep 18, 2019
Notification Of Possible Opposition Sent To Ib
Sep 18, 2019
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 11, 2019
Notification Of Notice Of Publication E-Mailed
Aug 29, 2019
Assigned To Lie
Aug 22, 2019
Approved For Pub - Principal Register
Aug 22, 2019
Examiner's Amendment Entered
Aug 22, 2019
Notification Of Examiners Amendment E-Mailed
Aug 22, 2019
Examiners Amendment E-Mailed
Aug 22, 2019
Examiners Amendment -Written
Aug 13, 2019
Teas/Email Correspondence Entered
Aug 13, 2019
Correspondence Received In Law Office
Aug 13, 2019
Teas Response To Office Action Received
Mar 2, 2019
Refusal Processed By Ib
Feb 14, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Feb 14, 2019
Refusal Processed By Mpu
Feb 6, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Feb 5, 2019
Non-Final Action Written
Feb 1, 2019
Application Filing Receipt Mailed
Jan 28, 2019
Assigned To Examiner
Jan 28, 2019
New Application Office Supplied Data Entered In Tram
Jan 24, 2019
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
